Gastroesophageal Reflux and PUD Flashcards
(44 cards)
pathophysiology GERD
- Results from the reflux of chyme from the stomach into the esophagus
- The resting tone of the lower esophageal sphincter (LES) is less than normal permits transient relaxation of the LES 1-2 hrs after eating
- This relaxation allows gastric contents to regurgitate into the esophagus
hormones that increase LES resting tone
gastrin
hormones that decrease LES sphincter tone
Estrogen
Progesterone
Glucagon
Secretin
Cholecystokinin
foods that decrease LES tone
Tobacco
Alcohol
Peppermint
Chocolate
Foods with high concentrations of fat or carbohydrates
medications that increase LES tone
bethanechol (Urecholine)
metoclopramide (Reglan)
pentobarbital (Nembutal)
histamine
antacids
medications that decrease LES tone
Anticholinergics
Theophylline
Caffeine
meperidine (Demerol)
calcium channel blockers
reflux esophagitis causes inflammatory response in the esophageal wall, which results in:
o Hyperemia
o Increased capillary permeability
o Edema
o Tissue fragility
o Erosion
o Ulcerations
o Fibrosis and basal cell hyperplasia
o Long term consequence: precancerous lesions (Barrett’s esophagus)
medications can be used to treat GERD in various ways
o increase LES tone
o reduce the amount of acid in chyme
o improve peristalsis
- decrease the time chyme is available to produce reflux
- decrease the exposure of the mucosa to highly acid material
drugs that improve LES sphincter tone
- metoclopramide and bethanechol
- antacids
metoclopramide and bethanechol for GERD
o Improve LES tone
o Have a prokinetic function
o Not considered monotherapy for GERD
o Most useful in combination w/ acid suppression for gastroparesis
o Do not heal esophageal lesions
antacids for GERD
o Serve dual purpose
- Improve LES tone
- Increase gastric pH
o Usually, patient initiated
drugs to reduce the amount of acid
histamine2 receptor antagonists and PPIs
H2RA for GERD
Act on parietal cells to decrease the amount of acid produced
Available OTC - usually pt initiated
Used as maintenance acid suppression or heartburn therapy in pts who do NOT have erosive GERD
AGA guidelines -> Trial of nighttime H2RAs for pts taking daytime PPIs
PPIs for GERD
1st line therapy for GERD
Decrease acid secretion by almost 100%
Improve esophageal healing by about 80%
drugs to improve peristalsis
Few patients continue to report s/s despite reduced acid secretion
o These patients may benefit from prokinetics
- Improve LES tone and peristalsis
Metoclopramide is used
drugs to decrease mucosal exposure in GERD
Two cytoprotective agents are available to decrease the exposure of the gastric mucosa to acid:
- Sucralfate (Carafate)
- misoprostol (Cytotec)
sucralfate (carafate) for GERD
- Acts largely as a barrier to cover sites undergoing erosive damage
- More often used with ulcers
misoprostol (Cytotec) for GERD
- Acts by increasing the production of cytoprotective mucus
- Reserved for when NSAIDs are a contributing factor to the increased acid load
goals of treatment for GERD
o Reduce or eliminate s/s
o Heal any esophageal lesions
o Prevent relapse
o Manage or prevent complications such as:
- Stricture
- Barrett’s esophagus
- Esophageal carcinoma
lifestyle modifications are central to the management of GERD
- antireflux maneuvers
- dietary changes
- cessation of smoking
- GERD s/s can be reduced with weight loss
antireflux maneuvers
Reduce back pressure on the LES from intra-abdominal contents
Sleep with HOB elevated 6-8 inches
Avoid the recumbent position within 3 hours after eating
Avoiding bending over within 3 hours of eating
Avoid exercise, especially strenuous exercise, within 3 hours of eating
Attain and maintain appropriate body weight
dietary changes for GERD
Reduce the total volume and acid content of the stomach
Eat moderate amounts of food at each meal. Do not gorge yourself
Avoid eating meals or bedtime snacks within 3 hours of going to bed
drug therapy for GERD step therapy
- lifestyle modifications and OTC antacids
- H2RAs is s/s are mild and no erosive disease is evident
- PPIs are 1st line therapy for pts w/ moderate to severe GERD or erosive disease
- reassess in 4-8 weeks
long-term use of PPI presents concerns
- Development of gastric cancer
- Increase in hip fractures in pts who are on PPIs longer than 2 years
- Vitamin B12 deficiency is a concern with chronic acid suppression